Results
1 -
10 of
15New Agents for Multiple Myeloma, Multiple Myeloma Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights, Journal of Hematology & Oncology Treatment of Patients in Third Relapse and Beyond Including Double-Refractory Disease, Personalized Therapy for Multiple Myeloma Treatment of MM: Upcoming Novel Therapies, Plasma Cell Dyscrasias The Discovery and Development of Eg5 Inhibitors for the Clinic, Kinesins and Cancer Clinical Trials of Mitotic Kinesin Inhibitors, Kinesins and Cancer A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma, Investigational New Drugs First-in-human phase 1 study of filanesib (ARRY-520), a kinesin spindle protein inhibitor, in patients with advanced solid tumors, Investigational New Drugs New drugs on the horizon. Treatment of myeloma in 2020, a perspective, memo - Magazine of European Medical Oncology Rasante Fortschritte in der Therapie des multiplen Myeloms, Im Focus Onkologie